跳至主要内容
临床试验/NCT07699627
NCT07699627尚未招募2 期

INCREDIBLE: INCREmental DIalysis and Diet for a Better Life Experience; Clinical Relevance of an "add-on" Ketosteril Supplementation on Incremental Haemodialysis Period in Incident Haemodialysis Patients. An Exploratory Randomized Controlled Trial

Centre Hospitalier le Mans1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2026年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
尚未招募
入组人数
70
试验地点
1
主要终点
Duration of incremental haemodialysis period

研究概览

简要总结

Previous studies suggest that the supplementation of essential amino acids and ketaoacids may prolong the duration of the incremental phase of peritoneal dialysis. There is no data on incremental haemodialysis patients. Such data would be highly needed to support the management of haemodialysis patients in the transition phase from "pre-dialysis" to "full dose" dialysis. In this context, investigator proposed a randomized "add on" trial, to evaluate the effect of the addition of Ketosteril to the usual nutritional plan to patients who start haemodialysis in incremental way.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients (aged 18 years or older)
  • Able and accepting to give informed consent
  • Starting iHD in the Centre Hospitalier Le Mans

排除标准

  • Denying informed consent
  • Acute kidney injury (AKI)
  • Life expectancy of less than 3 months, or kidney transplantation scheduled within 3 months
  • Cognitive impairment severe enough to limit understanding and acceptance of the study
  • Impossibility to regain kidney function (bilateral nephrectomy, documented irreversible complete destruction of the kidney tissue)
  • Patient with genetic disease affecting amino acid metabolism
  • Hypercalcemia defined as calcemia beyond the upper limit of normality according to the laboratory where the test is performed and persisting for at least one month
  • Hypersensitivity to the active substances or to any of the excipients of Ketosteril
  • Non-compliance to dialysis prescription
  • Previous enrolment in a randomized study using Ketosteril
  • Currently enrolled in another interventional clinical trial
  • Protected by law (patient under guardianship, minor, prisoner, pregnant or breastfeeding woman, …)

研究组 & 干预措施

Interventional arm

Experimental

Current dietary management with supplementation by Ketosteril

干预措施: Supplementation by ketosteril (Drug)

Control arm

No Intervention

Current dietary management, without Ketosteril

结局指标

主要结局

Duration of incremental haemodialysis period

时间窗: 24 months

Duration in months of the incremental haemodialysis period (defined as less than 3 times per week but excluding the cases in which dialysis frequency is reduced in the context of palliative and end-of life care)

次要结局

  • Hospitalization rates(24 months)
  • Combined outcome mortality and hospitalization(24 months)
  • Mortality(24 months)
  • Quality of life(24 months)
  • Nutritional status(24 months)
  • Costs(24 months)
  • Water saving(24 months)
  • Perceived diet quality(24 months)
  • Energy savings(24 months)
  • Waste Management(24 months)
  • Assessment of Appetite(24 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验